Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
[No title available]

Brain communications

Iacoangeli A, Fogh I, Selvackadunco S, Topp SD, Shatunov A, van Rheenen W, Al-Khleifat A, Opie-Martin S, Ratti A, Calvo A, Van Damme P, Robberecht W, Chio A, Dobson RJ, Hardiman O, Shaw CE, van den Berg LH, Andersen PM, Smith BN, Silani V, Veldink JH, Breen G, Troakes C, Al-Chalabi A, Jones AR.
PMID: 34708205
Brain Commun. 2021 Oct 07;3(4):fcab236. doi: 10.1093/braincomms/fcab236. eCollection 2021.

Evidence indicates that common variants found in genome-wide association studies increase risk of disease through gene regulation via expression Quantitative Trait Loci. Using multiple genome-wide methods, we examined if Single Nucleotide Polymorphisms increase risk of Amyotrophic Lateral Sclerosis through...

Cite
Iacoangeli A, Fogh I, Selvackadunco S, et al. . Brain Commun. 2021;3(4):fcab236doi: 10.1093/braincomms/fcab236.
Iacoangeli, A., Fogh, I., Selvackadunco, S., Topp, S. D., Shatunov, A., van Rheenen, W., Al-Khleifat, A., Opie-Martin, S., Ratti, A., Calvo, A., Van Damme, P., Robberecht, W., Chio, A., Dobson, R. J., Hardiman, O., Shaw, C. E., van den Berg, L. H., Andersen, P. M., Smith, B. N., Silani, V., Veldink, J. H., Breen, G., Troakes, C., Al-Chalabi, A., & Jones, A. R. (2021). . Brain communications, 3(4), fcab236. https://doi.org/10.1093/braincomms/fcab236
Iacoangeli, Alfredo, et al. "." Brain communications vol. 3,4 (2021): fcab236. doi: https://doi.org/10.1093/braincomms/fcab236
Iacoangeli A, Fogh I, Selvackadunco S, Topp SD, Shatunov A, van Rheenen W, Al-Khleifat A, Opie-Martin S, Ratti A, Calvo A, Van Damme P, Robberecht W, Chio A, Dobson RJ, Hardiman O, Shaw CE, van den Berg LH, Andersen PM, Smith BN, Silani V, Veldink JH, Breen G, Troakes C, Al-Chalabi A, Jones AR. . Brain Commun. 2021 Oct 07;3(4):fcab236. doi: 10.1093/braincomms/fcab236. eCollection 2021. PMID: 34708205; PMCID: PMC8545614.
Copy Download .nbib Format: NLM
A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex.

Scientific reports

Jones AR, Iacoangeli A, Adey BN, Bowles H, Shatunov A, Troakes C, Garson JA, McCormick AL, Al-Chalabi A.
PMID: 34253796
Sci Rep. 2021 Jul 12;11(1):14283. doi: 10.1038/s41598-021-93742-3.

There is increasing evidence that endogenous retroviruses (ERVs) play a significant role in central nervous system diseases, including amyotrophic lateral sclerosis (ALS). Studies of ALS have consistently identified retroviral enzyme reverse transcriptase activity in patients. Evidence indicates that ERVs...

Cite
Jones AR, Iacoangeli A, Adey BN, et al. A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex. Sci Rep. 2021;11(1):14283doi: 10.1038/s41598-021-93742-3.
Jones, A. R., Iacoangeli, A., Adey, B. N., Bowles, H., Shatunov, A., Troakes, C., Garson, J. A., McCormick, A. L., & Al-Chalabi, A. (2021). A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex. Scientific reports, 11(1), 14283. https://doi.org/10.1038/s41598-021-93742-3
Jones, Ashley R, et al. "A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex." Scientific reports vol. 11,1 (2021): 14283. doi: https://doi.org/10.1038/s41598-021-93742-3
Jones AR, Iacoangeli A, Adey BN, Bowles H, Shatunov A, Troakes C, Garson JA, McCormick AL, Al-Chalabi A. A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex. Sci Rep. 2021 Jul 12;11(1):14283. doi: 10.1038/s41598-021-93742-3. PMID: 34253796; PMCID: PMC8275748.
Copy Download .nbib Format: NLM
[No title available]

Brain communications

Iacoangeli A, Fogh I, Selvackadunco S, Topp SD, Shatunov A, van Rheenen W, Al-Khleifat A, Opie-Martin S, Ratti A, Calvo A, Van Damme P, Robberecht W, Chio A, Dobson RJ, Hardiman O, Shaw CE, van den Berg LH, Andersen PM, Smith BN, Silani V, Veldink JH, Breen G, Troakes C, Al-Chalabi A, Jones AR.
PMID: 34708205
Brain Commun. 2021 Oct 07;3(4):fcab236. doi: 10.1093/braincomms/fcab236. eCollection 2021.

Evidence indicates that common variants found in genome-wide association studies increase risk of disease through gene regulation via expression Quantitative Trait Loci. Using multiple genome-wide methods, we examined if Single Nucleotide Polymorphisms increase risk of Amyotrophic Lateral Sclerosis through...

Cite
Iacoangeli A, Fogh I, Selvackadunco S, et al. . Brain Commun. 2021;3(4):fcab236doi: 10.1093/braincomms/fcab236.
Iacoangeli, A., Fogh, I., Selvackadunco, S., Topp, S. D., Shatunov, A., van Rheenen, W., Al-Khleifat, A., Opie-Martin, S., Ratti, A., Calvo, A., Van Damme, P., Robberecht, W., Chio, A., Dobson, R. J., Hardiman, O., Shaw, C. E., van den Berg, L. H., Andersen, P. M., Smith, B. N., Silani, V., Veldink, J. H., Breen, G., Troakes, C., Al-Chalabi, A., & Jones, A. R. (2021). . Brain communications, 3(4), fcab236. https://doi.org/10.1093/braincomms/fcab236
Iacoangeli, Alfredo, et al. "." Brain communications vol. 3,4 (2021): fcab236. doi: https://doi.org/10.1093/braincomms/fcab236
Iacoangeli A, Fogh I, Selvackadunco S, Topp SD, Shatunov A, van Rheenen W, Al-Khleifat A, Opie-Martin S, Ratti A, Calvo A, Van Damme P, Robberecht W, Chio A, Dobson RJ, Hardiman O, Shaw CE, van den Berg LH, Andersen PM, Smith BN, Silani V, Veldink JH, Breen G, Troakes C, Al-Chalabi A, Jones AR. . Brain Commun. 2021 Oct 07;3(4):fcab236. doi: 10.1093/braincomms/fcab236. eCollection 2021. PMID: 34708205; PMCID: PMC8545614.
Copy Download .nbib Format: NLM
Cross-reactive probes on Illumina DNA methylation arrays: a large study on ALS shows that a cautionary approach is warranted in interpreting epigenome-wide association studies.

NAR genomics and bioinformatics

Hop PJ, Zwamborn RAJ, Hannon EJ, Dekker AM, van Eijk KR, Walker EM, Iacoangeli A, Jones AR, Shatunov A, Khleifat AA, Opie-Martin S, Shaw CE, Morrison KE, Shaw PJ, McLaughlin RL, Hardiman O, Al-Chalabi A, Van Den Berg LH, Mill J, Veldink JH.
PMID: 33554115
NAR Genom Bioinform. 2020 Dec 17;2(4):lqaa105. doi: 10.1093/nargab/lqaa105. eCollection 2020 Dec.

Illumina DNA methylation arrays are a widely used tool for performing genome-wide DNA methylation analyses. However, measurements obtained from these arrays may be affected by technical artefacts that result in spurious associations if left unchecked. Cross-reactivity represents one of...

Cite
Hop PJ, Zwamborn RAJ, Hannon EJ, et al. Cross-reactive probes on Illumina DNA methylation arrays: a large study on ALS shows that a cautionary approach is warranted in interpreting epigenome-wide association studies. NAR Genom Bioinform. 2020;2(4):lqaa105doi: 10.1093/nargab/lqaa105.
Hop, P. J., Zwamborn, R. A. J., Hannon, E. J., Dekker, A. M., van Eijk, K. R., Walker, E. M., Iacoangeli, A., Jones, A. R., Shatunov, A., Khleifat, A. A., Opie-Martin, S., Shaw, C. E., Morrison, K. E., Shaw, P. J., McLaughlin, R. L., Hardiman, O., Al-Chalabi, A., Van Den Berg, L. H., Mill, J., & Veldink, J. H. (2020). Cross-reactive probes on Illumina DNA methylation arrays: a large study on ALS shows that a cautionary approach is warranted in interpreting epigenome-wide association studies. NAR genomics and bioinformatics, 2(4), lqaa105. https://doi.org/10.1093/nargab/lqaa105
Hop, Paul J, et al. "Cross-reactive probes on Illumina DNA methylation arrays: a large study on ALS shows that a cautionary approach is warranted in interpreting epigenome-wide association studies." NAR genomics and bioinformatics vol. 2,4 (2020): lqaa105. doi: https://doi.org/10.1093/nargab/lqaa105
Hop PJ, Zwamborn RAJ, Hannon EJ, Dekker AM, van Eijk KR, Walker EM, Iacoangeli A, Jones AR, Shatunov A, Khleifat AA, Opie-Martin S, Shaw CE, Morrison KE, Shaw PJ, McLaughlin RL, Hardiman O, Al-Chalabi A, Van Den Berg LH, Mill J, Veldink JH. Cross-reactive probes on Illumina DNA methylation arrays: a large study on ALS shows that a cautionary approach is warranted in interpreting epigenome-wide association studies. NAR Genom Bioinform. 2020 Dec 17;2(4):lqaa105. doi: 10.1093/nargab/lqaa105. eCollection 2020 Dec. PMID: 33554115; PMCID: PMC7745769.
Copy Download .nbib Format: NLM
Enrichment of .

eLife

Gilley J, Jackson O, Pipis M, Estiar MA, Al-Chalabi A, Danzi MC, van Eijk KR, Goutman SA, Harms MB, Houlden H, Iacoangeli A, Kaye J, Lima L, Ravits J, Rouleau GA, Schüle R, Xu J, Züchner S, Cooper-Knock J, Gan-Or Z, Reilly MM, Coleman MP.
PMID: 34796871
Elife. 2021 Nov 19;10. doi: 10.7554/eLife.70905.

SARM1, a protein with critical NADase activity, is a central executioner in a conserved programme of axon degeneration. We report seven rare missense or in-frame microdeletion human

Cite
Gilley J, Jackson O, Pipis M, et al. Enrichment of . Elife. 2021;10doi: 10.7554/eLife.70905.
Gilley, J., Jackson, O., Pipis, M., Estiar, M. A., Al-Chalabi, A., Danzi, M. C., van Eijk, K. R., Goutman, S. A., Harms, M. B., Houlden, H., Iacoangeli, A., Kaye, J., Lima, L., Ravits, J., Rouleau, G. A., Schüle, R., Xu, J., Züchner, S., Cooper-Knock, J., Gan-Or, Z., Reilly, M. M., & Coleman, M. P. (2021). Enrichment of . eLife, 10. https://doi.org/10.7554/eLife.70905
Gilley, Jonathan, et al. "Enrichment of ." eLife vol. 10 (2021). doi: https://doi.org/10.7554/eLife.70905
Gilley J, Jackson O, Pipis M, Estiar MA, Al-Chalabi A, Danzi MC, van Eijk KR, Goutman SA, Harms MB, Houlden H, Iacoangeli A, Kaye J, Lima L, Ravits J, Rouleau GA, Schüle R, Xu J, Züchner S, Cooper-Knock J, Gan-Or Z, Reilly MM, Coleman MP. Enrichment of . Elife. 2021 Nov 19;10. doi: 10.7554/eLife.70905. PMID: 34796871; PMCID: PMC8735862.
Copy Download .nbib Format: NLM
Enrichment of .

eLife

Gilley J, Jackson O, Pipis M, Estiar MA, Al-Chalabi A, Danzi MC, van Eijk KR, Goutman SA, Harms MB, Houlden H, Iacoangeli A, Kaye J, Lima L, Ravits J, Rouleau GA, Schüle R, Xu J, Züchner S, Cooper-Knock J, Gan-Or Z, Reilly MM, Coleman MP.
PMID: 34796871
Elife. 2021 Nov 19;10. doi: 10.7554/eLife.70905.

SARM1, a protein with critical NADase activity, is a central executioner in a conserved programme of axon degeneration. We report seven rare missense or in-frame microdeletion human

Cite
Gilley J, Jackson O, Pipis M, et al. Enrichment of . Elife. 2021;10doi: 10.7554/eLife.70905.
Gilley, J., Jackson, O., Pipis, M., Estiar, M. A., Al-Chalabi, A., Danzi, M. C., van Eijk, K. R., Goutman, S. A., Harms, M. B., Houlden, H., Iacoangeli, A., Kaye, J., Lima, L., Ravits, J., Rouleau, G. A., Schüle, R., Xu, J., Züchner, S., Cooper-Knock, J., Gan-Or, Z., Reilly, M. M., & Coleman, M. P. (2021). Enrichment of . eLife, 10. https://doi.org/10.7554/eLife.70905
Gilley, Jonathan, et al. "Enrichment of ." eLife vol. 10 (2021). doi: https://doi.org/10.7554/eLife.70905
Gilley J, Jackson O, Pipis M, Estiar MA, Al-Chalabi A, Danzi MC, van Eijk KR, Goutman SA, Harms MB, Houlden H, Iacoangeli A, Kaye J, Lima L, Ravits J, Rouleau GA, Schüle R, Xu J, Züchner S, Cooper-Knock J, Gan-Or Z, Reilly MM, Coleman MP. Enrichment of . Elife. 2021 Nov 19;10. doi: 10.7554/eLife.70905. PMID: 34796871; PMCID: PMC8735862.
Copy Download .nbib Format: NLM
Enrichment of .

eLife

Gilley J, Jackson O, Pipis M, Estiar MA, Al-Chalabi A, Danzi MC, van Eijk KR, Goutman SA, Harms MB, Houlden H, Iacoangeli A, Kaye J, Lima L, Ravits J, Rouleau GA, Schüle R, Xu J, Züchner S, Cooper-Knock J, Gan-Or Z, Reilly MM, Coleman MP.
PMID: 34796871
Elife. 2021 Nov 19;10. doi: 10.7554/eLife.70905.

SARM1, a protein with critical NADase activity, is a central executioner in a conserved programme of axon degeneration. We report seven rare missense or in-frame microdeletion human

Cite
Gilley J, Jackson O, Pipis M, et al. Enrichment of . Elife. 2021;10doi: 10.7554/eLife.70905.
Gilley, J., Jackson, O., Pipis, M., Estiar, M. A., Al-Chalabi, A., Danzi, M. C., van Eijk, K. R., Goutman, S. A., Harms, M. B., Houlden, H., Iacoangeli, A., Kaye, J., Lima, L., Ravits, J., Rouleau, G. A., Schüle, R., Xu, J., Züchner, S., Cooper-Knock, J., Gan-Or, Z., Reilly, M. M., & Coleman, M. P. (2021). Enrichment of . eLife, 10. https://doi.org/10.7554/eLife.70905
Gilley, Jonathan, et al. "Enrichment of ." eLife vol. 10 (2021). doi: https://doi.org/10.7554/eLife.70905
Gilley J, Jackson O, Pipis M, Estiar MA, Al-Chalabi A, Danzi MC, van Eijk KR, Goutman SA, Harms MB, Houlden H, Iacoangeli A, Kaye J, Lima L, Ravits J, Rouleau GA, Schüle R, Xu J, Züchner S, Cooper-Knock J, Gan-Or Z, Reilly MM, Coleman MP. Enrichment of . Elife. 2021 Nov 19;10. doi: 10.7554/eLife.70905. PMID: 34796871; PMCID: PMC8735862.
Copy Download .nbib Format: NLM
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis.

Journal of neurology, neurosurgery, and psychiatry

Shepheard SR, Parker MD, Cooper-Knock J, Verber NS, Tuddenham L, Heath P, Beauchamp N, Place E, Sollars ESA, Turner MR, Malaspina A, Fratta P, Hewamadduma C, Jenkins TM, McDermott CJ, Wang D, Kirby J, Shaw PJ.
PMID: 33589474
J Neurol Neurosurg Psychiatry. 2021 May;92(5):510-518. doi: 10.1136/jnnp-2020-325014. Epub 2021 Feb 14.

OBJECTIVE: The clinical utility of routine genetic sequencing in amyotrophic lateral sclerosis (ALS) is uncertain. Our aim was to determine whether routine targeted sequencing of 44 ALS-relevant genes would have a significant impact on disease subclassification and clinical care.METHODS:...

Cite
Shepheard SR, Parker MD, Cooper-Knock J, et al. Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2021;92(5):510-518doi: 10.1136/jnnp-2020-325014.
Shepheard, S. R., Parker, M. D., Cooper-Knock, J., Verber, N. S., Tuddenham, L., Heath, P., Beauchamp, N., Place, E., Sollars, E. S. A., Turner, M. R., Malaspina, A., Fratta, P., Hewamadduma, C., Jenkins, T. M., McDermott, C. J., Wang, D., Kirby, J., Shaw, P. J. (2021). Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. Journal of neurology, neurosurgery, and psychiatry, 92(5), 510-518. https://doi.org/10.1136/jnnp-2020-325014
Shepheard, Stephanie R, et al. "Value of systematic genetic screening of patients with amyotrophic lateral sclerosis." Journal of neurology, neurosurgery, and psychiatry vol. 92,5 (2021): 510-518. doi: https://doi.org/10.1136/jnnp-2020-325014
Shepheard SR, Parker MD, Cooper-Knock J, Verber NS, Tuddenham L, Heath P, Beauchamp N, Place E, Sollars ESA, Turner MR, Malaspina A, Fratta P, Hewamadduma C, Jenkins TM, McDermott CJ, Wang D, Kirby J, Shaw PJ. Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2021 May;92(5):510-518. doi: 10.1136/jnnp-2020-325014. Epub 2021 Feb 14. PMID: 33589474; PMCID: PMC8053339.
Copy Download .nbib Format: NLM
Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene.

Cell reports

Cooper-Knock J, Zhang S, Kenna KP, Moll T, Franklin JP, Allen S, Nezhad HG, Iacoangeli A, Yacovzada NY, Eitan C, Hornstein E, Elhaik E, Celadova P, Bose D, Farhan S, Fishilevich S, Lancet D, Morrison KE, Shaw CE, Al-Chalabi A, Veldink JH, Kirby J, Snyder MP, Shaw PJ.
PMID: 33535055
Cell Rep. 2021 Feb 02;34(5):108730. doi: 10.1016/j.celrep.2021.108730.

No abstract available.

Cite
Cooper-Knock J, Zhang S, Kenna KP, et al. Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene. Cell Rep. 2021;34(5):108730doi: 10.1016/j.celrep.2021.108730.
Cooper-Knock, J., Zhang, S., Kenna, K. P., Moll, T., Franklin, J. P., Allen, S., Nezhad, H. G., Iacoangeli, A., Yacovzada, N. Y., Eitan, C., Hornstein, E., Elhaik, E., Celadova, P., Bose, D., Farhan, S., Fishilevich, S., Lancet, D., Morrison, K. E., Shaw, C. E., Al-Chalabi, A., Veldink, J. H., Kirby, J., Snyder, M. P., & Shaw, P. J. (2021). Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene. Cell reports, 34(5), 108730. https://doi.org/10.1016/j.celrep.2021.108730
Cooper-Knock, Johnathan, et al. "Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene." Cell reports vol. 34,5 (2021): 108730. doi: https://doi.org/10.1016/j.celrep.2021.108730
Cooper-Knock J, Zhang S, Kenna KP, Moll T, Franklin JP, Allen S, Nezhad HG, Iacoangeli A, Yacovzada NY, Eitan C, Hornstein E, Elhaik E, Celadova P, Bose D, Farhan S, Fishilevich S, Lancet D, Morrison KE, Shaw CE, Al-Chalabi A, Veldink JH, Kirby J, Snyder MP, Shaw PJ. Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene. Cell Rep. 2021 Feb 02;34(5):108730. doi: 10.1016/j.celrep.2021.108730. PMID: 33535055; PMCID: PMC7856549.
Copy Download .nbib Format: NLM
Does genetic anticipation occur in familial Alexander disease?.

Neurogenetics

Hunt CK, Al Khleifat A, Burchill E, Ederle J, Al-Chalabi A, Sreedharan J.
PMID: 34046764
Neurogenetics. 2021 Jul;22(3):215-219. doi: 10.1007/s10048-021-00642-9. Epub 2021 May 28.

Alexander Disease (AxD) is a rare leukodystrophy caused by missense mutations of glial fibrillary acidic protein (GFAP). Primarily seen in infants and juveniles, it can present in adulthood. We report a family with inherited AxD in which the mother...

Cite
Hunt CK, Al Khleifat A, Burchill E, et al. Does genetic anticipation occur in familial Alexander disease?. Neurogenetics. 2021;22(3):215-219doi: 10.1007/s10048-021-00642-9.
Hunt, C. K., Al Khleifat, A., Burchill, E., Ederle, J., Al-Chalabi, A., & Sreedharan, J. (2021). Does genetic anticipation occur in familial Alexander disease?. Neurogenetics, 22(3), 215-219. https://doi.org/10.1007/s10048-021-00642-9
Hunt, Camille K, et al. "Does genetic anticipation occur in familial Alexander disease?." Neurogenetics vol. 22,3 (2021): 215-219. doi: https://doi.org/10.1007/s10048-021-00642-9
Hunt CK, Al Khleifat A, Burchill E, Ederle J, Al-Chalabi A, Sreedharan J. Does genetic anticipation occur in familial Alexander disease?. Neurogenetics. 2021 Jul;22(3):215-219. doi: 10.1007/s10048-021-00642-9. Epub 2021 May 28. PMID: 34046764; PMCID: PMC8241638.
Copy Download .nbib Format: NLM
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)

Peloso GM, van der Lee SJ, Destefano AL, Seshardi S.
PMID: 30422133
Alzheimers Dement (Amst). 2018 Sep 22;10:595-598. doi: 10.1016/j.dadm.2018.08.008. eCollection 2018.

INTRODUCTION: There is conflicting evidence whether high-density lipoprotein cholesterol (HDL-C) is a risk factor for Alzheimer's disease (AD) and dementia. Genetic variation in the cholesteryl ester transfer protein (METHODS: Ten single nucleotide polymorphisms within the RESULTS: Based on 10...

Cite
Peloso GM, van der Lee SJ, et al. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease. Alzheimers Dement (Amst). 2018;10:595-598doi: 10.1016/j.dadm.2018.08.008.
Peloso, G. M., van der Lee, S. J., Destefano, A. L., & Seshardi, S. (2018). Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease. Alzheimer's & dementia (Amsterdam, Netherlands), 10595-598. https://doi.org/10.1016/j.dadm.2018.08.008
Peloso, Gina M, et al. "Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 10 (2018): 595-598. doi: https://doi.org/10.1016/j.dadm.2018.08.008
Peloso GM, van der Lee SJ, Destefano AL, Seshardi S. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease. Alzheimers Dement (Amst). 2018 Sep 22;10:595-598. doi: 10.1016/j.dadm.2018.08.008. eCollection 2018. PMID: 30422133; PMCID: PMC6215982.
Copy Download .nbib Format: NLM
[No title available]

Brain communications

Iacoangeli A, Fogh I, Selvackadunco S, Topp SD, Shatunov A, van Rheenen W, Al-Khleifat A, Opie-Martin S, Ratti A, Calvo A, Van Damme P, Robberecht W, Chio A, Dobson RJ, Hardiman O, Shaw CE, van den Berg LH, Andersen PM, Smith BN, Silani V, Veldink JH, Breen G, Troakes C, Al-Chalabi A, Jones AR.
PMID: 34708205
Brain Commun. 2021 Oct 07;3(4):fcab236. doi: 10.1093/braincomms/fcab236. eCollection 2021.

Evidence indicates that common variants found in genome-wide association studies increase risk of disease through gene regulation via expression Quantitative Trait Loci. Using multiple genome-wide methods, we examined if Single Nucleotide Polymorphisms increase risk of Amyotrophic Lateral Sclerosis through...

Cite
Iacoangeli A, Fogh I, Selvackadunco S, et al. . Brain Commun. 2021;3(4):fcab236doi: 10.1093/braincomms/fcab236.
Iacoangeli, A., Fogh, I., Selvackadunco, S., Topp, S. D., Shatunov, A., van Rheenen, W., Al-Khleifat, A., Opie-Martin, S., Ratti, A., Calvo, A., Van Damme, P., Robberecht, W., Chio, A., Dobson, R. J., Hardiman, O., Shaw, C. E., van den Berg, L. H., Andersen, P. M., Smith, B. N., Silani, V., Veldink, J. H., Breen, G., Troakes, C., Al-Chalabi, A., & Jones, A. R. (2021). . Brain communications, 3(4), fcab236. https://doi.org/10.1093/braincomms/fcab236
Iacoangeli, Alfredo, et al. "." Brain communications vol. 3,4 (2021): fcab236. doi: https://doi.org/10.1093/braincomms/fcab236
Iacoangeli A, Fogh I, Selvackadunco S, Topp SD, Shatunov A, van Rheenen W, Al-Khleifat A, Opie-Martin S, Ratti A, Calvo A, Van Damme P, Robberecht W, Chio A, Dobson RJ, Hardiman O, Shaw CE, van den Berg LH, Andersen PM, Smith BN, Silani V, Veldink JH, Breen G, Troakes C, Al-Chalabi A, Jones AR. . Brain Commun. 2021 Oct 07;3(4):fcab236. doi: 10.1093/braincomms/fcab236. eCollection 2021. PMID: 34708205; PMCID: PMC8545614.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries